Plasma IGFBP-2 levels correlate with insulin resistance and could be used as a biomarker of insulin sensitivity [90] and may play an important role in the pathogenesis of obesity complications in early life [91]. The gene discussed is IGFBP2; the disease is obesity due to melanocortin 4 receptor deficiency.